<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: vaccine strains</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Universal flu vaccine holds promise</title>
   	 <description>An influenza vaccine that protects against death and serious complications from different strains of flu is a little closer to reality, Saint Louis University vaccine researchers have found.</description>
     <link>http://www.physorg.com/news160071564.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 27 Apr 2009 17:19:50 EST</pubDate>
	 <guid isPermaLink="false">news160071564</guid>
</item>
<item>
     <title>Better by design: Engineering flu vaccines</title>
   	 <description>A new computerized method of testing could help world health officials better identify flu vaccines that are effective against multiple strains of the disease. Rice University scientists who created the method say tests of data from bird flu and seasonal flu outbreaks suggest their method can better gauge the efficacy of proposed vaccines than can tests used today.</description>
     <link>http://www.physorg.com/news156521534.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Mar 2009 15:12:47 EST</pubDate>
	 <guid isPermaLink="false">news156521534</guid>
</item>
<item>
     <title>New generation of salmonella-based, single dose vaccine candidates to fight infant pneumonia</title>
   	 <description>One of the major challenges in modern vaccinology is to engineer vectors that are highly infectious, yet don't cause illness. Trickier still is to ensure that such weapons against infectious disease can be safely disarmed, once their immunogenic work is done. Roy Curtiss, an investigator of vaccines and infectious diseases at Arizona State University's Biodesign Institute, has pursued these goals for 30 years. </description>
     <link>http://www.physorg.com/news151003976.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 12 Jan 2009 17:32:56 EST</pubDate>
	 <guid isPermaLink="false">news151003976</guid>
</item>


</channel>
</rss>

